Zhejiang Jolly Pharmaceutical Co Ltd (300181) - Total Assets
Based on the latest financial reports, Zhejiang Jolly Pharmaceutical Co Ltd (300181) holds total assets worth CN¥5.33 Billion CNY (≈ $780.05 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Zhejiang Jolly Pharmaceutical Co Ltd - Total Assets Trend (2007–2025)
This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see market cap of Zhejiang Jolly Pharmaceutical Co Ltd for the company's overall valuation and market capitalisation.
Zhejiang Jolly Pharmaceutical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Zhejiang Jolly Pharmaceutical Co Ltd's total assets of CN¥5.33 Billion consist of 50.8% current assets and 49.3% non-current assets. Review how much debt does Zhejiang Jolly Pharmaceutical Co Ltd carry to assess the company's total debt and financial obligations.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 14.5% |
| Accounts Receivable | CN¥785.53 Million | 16.7% |
| Inventory | CN¥531.81 Million | 11.3% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥113.38 Million | 2.4% |
| Goodwill | CN¥130.32 Million | 2.8% |
Asset Composition Trend (2007–2025)
This chart illustrates how Zhejiang Jolly Pharmaceutical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See 300181 share price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Zhejiang Jolly Pharmaceutical Co Ltd's current assets represent 50.8% of total assets in 2025, an increase from 37.9% in 2007.
- Cash Position: Cash and equivalents constituted 14.5% of total assets in 2025, up from 5.7% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 4.0% of total assets, a decrease from 13.0% in 2007.
- Asset Diversification: The largest asset category is accounts receivable at 16.7% of total assets.
Zhejiang Jolly Pharmaceutical Co Ltd Competitors by Total Assets
Key competitors of Zhejiang Jolly Pharmaceutical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Pfizer Inc
NYSE:PFE
|
USA | $201.13 Billion |
|
AbbVie Inc
NYSE:ABBV
|
USA | $136.46 Billion |
|
Merck & Company Inc
NYSE:MRK
|
USA | $129.80 Billion |
|
AstraZeneca PLC
MX:AZNN
|
Mexico | MX$114.07 Billion |
|
Novartis AG ADR
NYSE:NVS
|
USA | $122.03 Billion |
|
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357
|
China | CN¥2.89 Billion |
|
Firebrick Pharma Ltd
AU:FRE
|
Australia | AU$2.28 Million |
|
Eli Lilly and Company
SA:LILY34
|
Brazil | R$116.58 Billion |
Zhejiang Jolly Pharmaceutical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.55 | 2.01 | 1.76 |
| Quick Ratio | 1.21 | 1.62 | 1.33 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥923.18 Million | CN¥1.22 Billion | CN¥386.89 Million |
Zhejiang Jolly Pharmaceutical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Zhejiang Jolly Pharmaceutical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.12 |
| Latest Market Cap to Assets Ratio | 0.29 |
| Asset Growth Rate (YoY) | 18.0% |
| Total Assets | CN¥4.71 Billion |
| Market Capitalization | $1.37 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Zhejiang Jolly Pharmaceutical Co Ltd's assets below their book value (0.29x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Zhejiang Jolly Pharmaceutical Co Ltd's assets grew by 18.0% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
The table below shows the annual total assets of Zhejiang Jolly Pharmaceutical Co Ltd from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥4.71 Billion ≈ $689.47 Million |
+18.03% |
| 2024-12-31 | CN¥3.99 Billion ≈ $584.15 Million |
+10.06% |
| 2023-12-31 | CN¥3.63 Billion ≈ $530.75 Million |
-0.33% |
| 2022-12-31 | CN¥3.64 Billion ≈ $532.52 Million |
+32.40% |
| 2021-12-31 | CN¥2.75 Billion ≈ $402.20 Million |
+11.28% |
| 2020-12-31 | CN¥2.47 Billion ≈ $361.42 Million |
+20.44% |
| 2019-12-31 | CN¥2.05 Billion ≈ $300.07 Million |
-2.99% |
| 2018-12-31 | CN¥2.11 Billion ≈ $309.32 Million |
-1.79% |
| 2017-12-31 | CN¥2.15 Billion ≈ $314.97 Million |
+5.62% |
| 2016-12-31 | CN¥2.04 Billion ≈ $298.20 Million |
+10.12% |
| 2015-12-31 | CN¥1.85 Billion ≈ $270.79 Million |
+56.62% |
| 2014-12-31 | CN¥1.18 Billion ≈ $172.89 Million |
+25.44% |
| 2013-12-31 | CN¥941.90 Million ≈ $137.83 Million |
+8.99% |
| 2012-12-31 | CN¥864.19 Million ≈ $126.46 Million |
+2.40% |
| 2011-12-31 | CN¥843.91 Million ≈ $123.49 Million |
+142.05% |
| 2010-12-31 | CN¥348.64 Million ≈ $51.02 Million |
+17.09% |
| 2009-12-31 | CN¥297.77 Million ≈ $43.57 Million |
+6.39% |
| 2008-12-31 | CN¥279.87 Million ≈ $40.95 Million |
+11.39% |
| 2007-12-31 | CN¥251.25 Million ≈ $36.77 Million |
-- |
About Zhejiang Jolly Pharmaceutical Co Ltd
Zhejiang Jolly Pharmaceutical Co.,LTD engages in the research, production, and marketing of Chinese medicinal products in the People's Republic of China and internationally. It offers Wuling capsule to treat insomnia, amnesia, heart palpitations, lack of energy, lassitude in loin and legs, and giddy tinnitus, as well as deficiency of energy and weak pulse caused by the disharmony of heart and kid… Read more